e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Invasive and noninvasive methods to assess airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Unaltered MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in the airways of occasional smokers after acute exposure to cigarette smoke
P. Glader, B. M. Eldh, K. Andelid, M. Sjöstrand, C. Malmhäll, I. Qvarfordt, G. Riise, A. Lindén (Göteborg, Sweden)
Source:
Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation
Session:
Invasive and noninvasive methods to assess airway inflammation
Session type:
Thematic Poster Session
Number:
3463
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Glader, B. M. Eldh, K. Andelid, M. Sjöstrand, C. Malmhäll, I. Qvarfordt, G. Riise, A. Lindén (Göteborg, Sweden). Unaltered MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in the airways of occasional smokers after acute exposure to cigarette smoke. Eur Respir J 2007; 30: Suppl. 51, 3463
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Measurement of neutrophil activity following acute cigarette smoking in heavy smokers with and without COPD
Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma
Year: 2007
Effect of acute exposure to tobacco smoke on soluble CC16 protein in BAL fluid from occasional smokers
Source: Eur Respir J 2004; 24: Suppl. 48, 468s
Year: 2004
Potential association between cigarette smoking and IL-18 levels in induced sputum of healthy and asthma smokers
Source: Eur Respir J 2007; 30: Suppl. 51, 363s
Year: 2007
Comparison of HSP mRNA relative levels in sputum of COPD patients and subjects exposed to wood smoke and/or cigarette smoke.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
Acute effect of smoking in normal and asthmatic smokers
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Acute effect of passive cigarette smoking on airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 129s
Year: 2005
Influence of tobacco smoke exposure on inflammatory cytokines and cell differentials in induced sputum – from environmental smoke exposure to active smoking and COPD
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
COPD fibroblasts are more responsive to cigarette smoke exposure
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Influence of cigarette smoking history on HDAC2 expression in central and peripheral airways in smokers with and without COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006
Secondhand tobacco smoke exposure and the risk of COPD
Source: Annual Congress 2004 - Longitudinal studies and determinants of lung function and COPD
Year: 2004
Acute cigarette smoke exposure in mice promotes airway inflammation consistent with the hallmarks of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 80s
Year: 2003
Cigarette smoking induced elevated CXCL5 levels in BALF and plasma of patients with COPD
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
Effects of one year smoking cessation on inflammation in induced sputum of smokers with and without COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002
Cigarette smoking modifies the association between IL-18 levels in induced sputum and airway heperresponsiveness in asthmatics
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008
IL-10 resolves the neutrophilic inflammation in mice exposed to cigarette smoke
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Chronic exposure to allergen and cigarette smoke induces predominantly features of COPD
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011
Age related alterations in sputum and plasma MMP-9 and TIMP-1 levels in healthy non-smokers and smokers
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD
Source: Eur Respir J 2007; 29: 51-55
Year: 2007
Decreased expression of VEGF in the lungs of cigarettes smoke exposure mice
Source: Eur Respir J 2003; 22: Suppl. 45, 434s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept